Recursion Pharmaceuticals, Inc. Share Price
Equities
RXRX
US75629V1044
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.12 USD | +3.57% | +10.48% | -17.65% |
18/04 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
16/04 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
Sales 2024 * | 53.92M 4.5B | Sales 2025 * | 60.67M 5.06B | Capitalization | 1.93B 161B |
---|---|---|---|---|---|
Net income 2024 * | -411M -34.27B | Net income 2025 * | -481M -40.1B | EV / Sales 2024 * | 29.9 x |
Net cash position 2024 * | 322M 26.84B | Net cash position 2025 * | 279M 23.23B | EV / Sales 2025 * | 27.3 x |
P/E ratio 2024 * |
-4.78
x | P/E ratio 2025 * |
-4.33
x | Employees | 500 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.44% |
1 day | +3.57% | ||
1 week | +10.48% | ||
Current month | -18.56% | ||
1 month | -20.16% | ||
3 months | -16.97% | ||
6 months | +53.79% | ||
Current year | -17.65% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 41 | 05/13/05 | |
Blake Borgeson
FOU | Founder | 42 | 05/13/05 |
Dean Li
FOU | Founder | 62 | 05/13/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 20/20/20 |
Chairman | 60 | 01/20/01 | |
Dean Li
FOU | Founder | 62 | 05/13/05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.51% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 8.12 | +3.57% | 4,394,004 |
25/24/25 | 7.84 | -1.26% | 4,382,391 |
24/24/24 | 7.94 | +3.12% | 7,206,016 |
23/24/23 | 7.7 | +1.32% | 5,111,318 |
22/24/22 | 7.6 | +3.40% | 3,946,342 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.65% | 1.93B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- RXRX Stock